Ontario’s Heart Valve Disease Awareness Act, 2024 formally designates February 22 as Heart Valve Disease Awareness Day and the week beginning on the third Monday of September as Heart Valve Disease Awareness Week. The designations are intended to focus attention on symptoms, risk factors, early detection, and treatment options for heart valve disease.
The Act is a recognition measure, not a healthcare delivery statute. It does not create screening programs, impose duties on healthcare providers, allocate funding, or establish targets for diagnosis or treatment.
Its practical effect is to provide recurring dates that public agencies, clinicians, advocacy groups, and community organizations can use for education and outreach.
At a Glance
What It Does
The Act proclaims February 22 of each year as Heart Valve Disease Awareness Day. It also proclaims the week beginning on the third Monday of September each year as Heart Valve Disease Awareness Week.
Who It Affects
The designations directly concern Ontario residents, particularly older adults and people with cardiovascular risk factors, as well as healthcare providers, patient organizations, and public health communicators. They also give provincial and community organizations a statutory basis for coordinating awareness activities.
Why It Matters
The Act recognizes a condition whose symptoms can be mistaken for ordinary aging and whose consequences can be serious when diagnosis is delayed. Its significance lies in elevating awareness without changing clinical practice, insurance coverage, or access to care.
More articles like this one.
A weekly email with all the latest developments on this topic.
What This Bill Actually Does
The Act addresses heart valve disease through public recognition rather than regulation. It identifies awareness and early detection as important because the disease can interrupt blood flow, produce symptoms ranging from fatigue and shortness of breath to fainting and swelling, and in some cases progress to stroke, heart failure, or death.
The preamble also points to older adults and people with conditions such as high blood pressure, high cholesterol, or diabetes as groups that may warrant particular attention.
The statute creates two recurring observances. February 22 becomes Heart Valve Disease Awareness Day, while the week that starts on the third Monday of September becomes Heart Valve Disease Awareness Week.
The dates align Ontario’s observances with dates already used by cardiovascular and patient organizations, which may make it easier for those organizations to coordinate campaigns across jurisdictions.The Act does not direct the Ministry of Health, hospitals, physicians, or public health units to take a particular action. It does not require stethoscope checks or other screening, establish referral pathways, mandate public reporting, or change the clinical standard of care.
Any education, screening, or outreach that occurs under these designations would depend on existing programs and the voluntary decisions of relevant organizations.The law also contains no dedicated funding, enforcement mechanism, eligibility rule, or individual entitlement. Its operative provisions are limited to the two proclamations, with the Act taking effect immediately upon Royal Assent and using a short title for citation.
The Five Things You Need to Know
The annual day falls on February 22, while the annual awareness week begins on the third Monday of September.
The Act creates no requirement for physicians or other providers to screen patients for heart valve disease.
The statute contains no appropriation, grant program, administrative body, reporting duty, or enforcement provision.
The preamble identifies older adults and people with cardiovascular risk factors as groups for whom regular screening may be particularly important, but it does not turn that observation into a legal obligation.
The Act comes into force on the day it receives Royal Assent, rather than on a later prescribed date.
Section-by-Section Breakdown
Every bill we cover gets an analysis of its key sections.
Sets out the public-health rationale
The preamble describes heart valve disease, its potential consequences, the prevalence of the condition among older adults, and the value of early detection. It also identifies symptoms and risk factors that awareness campaigns may address.
Because the preamble does not create operative duties, it functions primarily as interpretive and public-facing context. It explains why the Legislature selected these observances without establishing a clinical program or legally enforceable standard.
Creates Heart Valve Disease Awareness Day
Section 1 proclaims February 22 in each year as Heart Valve Disease Awareness Day. The provision creates a fixed annual date that organizations can use for communications, educational events, and patient-support activities.
The section does not specify who must organize activities or what those activities must contain. Its effect is therefore symbolic and coordinating rather than regulatory.
Creates Heart Valve Disease Awareness Week
Section 2 proclaims the week beginning on the third Monday of September in each year as Heart Valve Disease Awareness Week. Defining the week by its starting weekday creates a recurring calendar period without requiring annual administrative designation.
The provision may support broader campaigns than the single-day observance, including community education and professional outreach. It still leaves participation, content, and funding to existing organizations and programs.
Sets commencement and short title
Section 3 brings the Act into force on the day it receives Royal Assent. That rule avoids a delayed implementation period because the Act creates calendar designations rather than operational systems.
Section 4 provides the short title, “Heart Valve Disease Awareness Act, 2024,” for citation and reference.
This bill is one of many.
Codify tracks hundreds of bills on this topic across all five countries.
Explore this topic in Codify Search →Who Benefits and Who Bears the Cost
Every bill creates winners and losers. Here's who stands to gain and who bears the cost.
Who Benefits
- Ontarians living with heart valve disease may gain greater public recognition of the condition and more opportunities to encounter information about symptoms, risk factors, and treatment.
- Older adults and people with cardiovascular risk factors may benefit from campaigns that encourage discussion of symptoms or abnormal heart sounds with healthcare providers.
- Patient organizations and cardiovascular charities receive two statutory anchor dates for coordinating provincial education, fundraising, and support activities.
- Healthcare professionals and public health communicators can use the designated periods to organize outreach without waiting for a new statutory awareness date to be created.
Who Bears the Cost
- Patient organizations and charities may face added pressure to produce campaigns and events around the designated dates, even though the Act provides no dedicated funding.
- Public health units, hospitals, and healthcare providers may incur voluntary communication and event costs if they choose to participate in the observances.
- People seeking improved diagnosis or treatment may see limited immediate practical change because the Act does not expand screening, specialist capacity, or treatment access.
- Ontario policymakers and health administrators receive no statutory implementation framework, leaving the impact of the observances dependent on existing priorities and resources.
Key Issues
The Core Tension
The Act seeks to address a serious and potentially under-recognized disease through a low-cost public-awareness measure, but awareness alone does not ensure screening, diagnosis, or treatment. A stronger statutory response could create more measurable health benefits while also imposing costs, clinical obligations, and administrative demands that this Act deliberately avoids.
The central limitation is the gap between recognition and delivery. The Act identifies early detection as important, but it does not define which patients should be screened, who should pay for outreach, how suspected cases should be referred, or how Ontario should measure whether awareness leads to earlier diagnosis.
The preamble’s reference to a simple stethoscope check may encourage attention to heart murmurs, but the operative provisions do not require or standardize that practice.
The calendar choices also create coordination benefits without guaranteeing consistent messaging. Organizations may align with the annual dates, but activities can vary significantly in reach and quality across communities.
Without funding, reporting, or evaluation requirements, the Legislature will have little statutory information about whether the observances change patient behaviour, provider practice, or outcomes. The Act’s immediate commencement is uncomplicated, but the absence of implementation machinery means its practical effect rests almost entirely on voluntary uptake.
There's more to this law than the bill.
Codify Laws traces every connection across the legislative lifecycle.